Publications by authors named "Bas D Koster"

Claim this Profile
L
Local delivery of low-dose anti-CTLA-4 to the melanoma lymphatic basin leads to systemic T reduction and effector T cell activation.
Kim M van Pul, Jessica C L Notohardjo, Marieke F Fransen, Bas D Koster, Anita G M Stam

Sci Immunol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In the mix: the potential benefits of adding GM-CSF to CpG-B in the local treatment of patients with early-stage melanoma.
Bas D Koster, Tamarah D de Jong, Mari F C M van den Hout, Berbel J R Sluijter, Ronald J C L M Vuylsteke

Oncoimmunology· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T cell infiltration on local CpG-B delivery in early-stage melanoma is predominantly related to CLEC9ACD141 cDC1 and CD14 antigen-presenting cell recruitment.
Bas D Koster, Marta López González, Mari Fcm van den Hout, Annelies W Turksma, Berbel Jr Sluijter

J Immunother Cancer· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unlocking the therapeutic potential of primary tumor-draining lymph nodes.
Jossie Rotman, Bas D Koster, Ekaterina S Jordanova, A Marijne Heeren, Tanja D de Gruijl

Cancer Immunol Immunother· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial.
Bas D Koster, Saskia J A M Santegoets, Jorien Harting, Arnold Baars, S Marieke van Ham

Cancer Immunol Immunother· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial.
Bas D Koster, Saskia J A M Santegoets, Jorien Harting, Arnold Baars, S Marieke van Ham

Cancer Immunol Immunother· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melanoma Sequentially Suppresses Different DC Subsets in the Sentinel Lymph Node, Affecting Disease Spread and Recurrence.
Mari F C M van den Hout, Bas D Koster, Berbel J R Sluijter, Barbara G Molenkamp, Rieneke van de Ven

Cancer Immunol Res· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Local Adjuvant Treatment with Low-Dose CpG-B Offers Durable Protection against Disease Recurrence in Clinical Stage I-II Melanoma: Data from Two Randomized Phase II Trials.
Bas D Koster, Mari F C M van den Hout, Berbel J R Sluijter, Barbara G Molenkamp, Ronald J C L M Vuylsteke

Clin Cancer Res· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent developments and future challenges in immune checkpoint inhibitory cancer treatment.
Bas D Koster, Tanja D de Gruijl, Alfons J M van den Eertwegh

Curr Opin Oncol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arming the Melanoma Sentinel Lymph Node through Local Administration of CpG-B and GM-CSF: Recruitment and Activation of BDCA3/CD141(+) Dendritic Cells and Enhanced Cross-Presentation.
Berbel J R Sluijter, Mari F C M van den Hout, Bas D Koster, Paul A M van Leeuwen, Famke L Schneiders

Cancer Immunol Res· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High and interrelated rates of PD-L1+CD14+ antigen-presenting cells and regulatory T cells mark the microenvironment of metastatic lymph nodes from patients with cervical cancer.
A Marijne Heeren, Bas D Koster, Sanne Samuels, Debbie M Ferns, Dafni Chondronasiou

Cancer Immunol Res· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis